Synlait Milk Limited has secured important amendments and waivers to its syndicated bank facilities, aligning its financial covenants with the upcoming sale of its North Island assets scheduled for April 2026.
- Extension of $50 million limit step-down on Revolving Credit Facility A to April 30, 2026
- Waivers and amendments granted for EBITDA thresholds and interest cover ratios
- Suspension of net senior leverage ratio covenant for full year 2026
- Potential extension of Revolving Credit Facility A2 maturity pending lender approval
- Asset sale completion on track for April 1, 2026
Synlait's Strategic Banking Adjustments
Synlait Milk Limited has announced a series of amendments and waivers to its syndicated bank facilities, reflecting a proactive approach to managing liquidity and covenant compliance ahead of a significant asset sale. The company is preparing for the completion of its North Island assets sale, expected on 1 April 2026, which will influence its financial position and banking arrangements.
Key Amendments to Credit Facilities
Central to the update is the extension of the $50 million "limit step-down" on Synlait's Revolving Credit Facility A. Originally scheduled for 28 February 2026, this reduction in facility limit will now occur on the earlier of 30 April 2026 or three business days after the asset sale settlement. This adjustment provides Synlait with additional breathing room to manage cash flows during this transitional period.
In addition to the limit extension, Synlait has secured waivers for the quarterly minimum EBITDA Event of Review threshold for the half year ending 31 January 2026. The company also agreed to amended EBITDA thresholds for the subsequent periods ending 30 April and 31 July 2026. These changes acknowledge the temporary impact of the asset sale and operational factors on earnings.
Financial Covenant Flexibility
Further easing comes with the suspension of the net senior leverage ratio covenant for the full year ending 31 July 2026. This ratio, which measures the company’s debt relative to earnings, is a critical indicator for lenders. The interest cover ratio, which compares earnings to interest expenses, has also been waived for the January 2026 test date and amended for the April and July 2026 dates. These adjustments collectively provide Synlait with enhanced flexibility to navigate the financial impacts of its strategic moves.
Pending Approvals and Next Steps
Synlait also indicated the potential extension of the maturity date for its Revolving Credit Facility A2, currently set to mature by 31 March 2026. This extension aims to align with the revised step-down date of Facility A but remains subject to approval by one remaining lender. The outcome of this approval will be closely watched by investors and creditors alike.
Overall, these facility amendments and covenant waivers reflect Synlait’s careful financial stewardship as it prepares to complete a major asset sale. The company’s ability to secure these banking adjustments ahead of the transaction provides a degree of confidence in its liquidity management and strategic planning.
Bottom Line?
Synlait’s banking facility adjustments set the stage for a smoother transition post-asset sale, but lender approval and covenant compliance remain key watchpoints.
Questions in the middle?
- Will the final lender approve the extension of Revolving Credit Facility A2 maturity?
- How will the asset sale proceeds impact Synlait’s overall debt profile and future covenant compliance?
- What operational changes might affect EBITDA and interest cover ratios in the coming quarters?